OTCMKTS:WXXWY WuXi Biologics (Cayman) (WXXWY) Stock Price, News & Analysis → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free WXXWY Stock Alerts $3.59 +0.12 (+3.46%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$3.53▼$3.6550-Day Range$3.40▼$7.7852-Week Range$3.26▼$13.84Volume58,708 shsAverage Volume307,856 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi Biologics (Cayman) alerts: Email Address Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. About WuXi Biologics (Cayman) Stock (OTCMKTS:WXXWY)WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.Read More WXXWY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WXXWY Stock News HeadlinesMarch 26, 2024 | prnewswire.comWuXi Biologics Reports Solid 2023 Annual ResultsMarch 22, 2024 | prnewswire.comWuXi Biologics Named to CDP 'A List' for Water SecurityMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.March 22, 2024 | americanbankingnews.comWuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Down 0.6% March 8, 2024 | msn.comHong Kong Stocks: WuXi Biologics Shares Tumble on US Biotech Bill ConcernsMarch 5, 2024 | finance.yahoo.comWuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change AssessmentFebruary 21, 2024 | prnewswire.comWuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar SustainalyticsFebruary 14, 2024 | markets.businessinsider.comWuxi Biologics: Navigating the Biosecure Act with Resilience and OptimismMarch 29, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.January 31, 2024 | finance.yahoo.comWuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in IrelandJanuary 30, 2024 | markets.businessinsider.comWuxi Biologics (Cayman) Buy Rating: Growth Potential and Strong Compliance StandardsJanuary 28, 2024 | bloomberg.comWuXi Bio Denies Military Ties After Shares Slumped on US BillJanuary 26, 2024 | finance.yahoo.comWuXi AppTec, Wuxi Bio Tumble as US Lawmakers Propose BanJanuary 26, 2024 | finance.yahoo.comUS lawmaker moves bill to ban Chinese biotech firms from federal contracts, alleging complicity with militaryJanuary 26, 2024 | finance.yahoo.comChinese Biotech Stocks Plunge on Proposed U.S. LegislationJanuary 24, 2024 | finance.yahoo.comWuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC EffectJanuary 23, 2024 | finance.yahoo.comWuXi Biologics (Cayman) Inc. (WXXWY)January 23, 2024 | morningstar.comWuXi Biologics (Cayman) Inc ADR WXXWYJanuary 17, 2024 | finance.yahoo.comWuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™January 12, 2024 | markets.businessinsider.comWuxi Biologics: A Buy Rating on Robust Growth and Strong Pipeline ProspectsJanuary 10, 2024 | finance.yahoo.comWuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product CandidatesJanuary 8, 2024 | finance.yahoo.comWuXi Biologics to Increase Manufacturing Capacity in MassachusettsDecember 26, 2023 | morningstar.comWuXi Biologics (Cayman) Inc ADRDecember 12, 2023 | finance.yahoo.comWuXi Biologics Named to 2023 Dow Jones Sustainability World IndexDecember 8, 2023 | finance.yahoo.comWuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability RatingDecember 6, 2023 | msn.comWuXi Bio Share Price Remains Under Pressure; Analysts Trim TargetsDecember 6, 2023 | morningstar.comWuXi Biologics (Cayman) Inc 02269See More Headlines Receive WXXWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi Biologics (Cayman) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:WXXWY CUSIPN/A CIKN/A Webwww.wuxibiologics.com.cn Phone8651081831205FaxN/AEmployees12,397Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Founder & Chairman Dr. Zhisheng Chen (Age 51)CEO & Executive Director Comp: $625.07kDr. Weichang Zhou Ph.D. (Age 60)President of Global Biologics Development & Operations, CTO and Executive Director Comp: $419.91kMr. Ming Tu (Age 56)CFO & Executive VP Ms. Tang Shaogui M.B.A.VP and Head of Global Communications, Operations & ESGDr. Jijie Gu (Age 58)Executive VP & Chief Scientific Officer Ms. Eileen WangIR Senior DirectorMs. Cong Ding J.D.VP & Head of Legal DepartmentHe WangChief Compliance Officer, Senior VP and Head of Global Compliance & Risk ManagementMs. Li XiongVP & Head of Global Human ResourcesMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors WXXWY Stock Analysis - Frequently Asked Questions How have WXXWY shares performed in 2024? WuXi Biologics (Cayman)'s stock was trading at $7.45 on January 1st, 2024. Since then, WXXWY stock has decreased by 51.8% and is now trading at $3.59. View the best growth stocks for 2024 here. Are investors shorting WuXi Biologics (Cayman)? WuXi Biologics (Cayman) saw a increase in short interest in March. As of March 15th, there was short interest totaling 27,500 shares, an increase of 38.2% from the February 29th total of 19,900 shares. Based on an average daily trading volume, of 541,800 shares, the days-to-cover ratio is currently 0.1 days. View WuXi Biologics (Cayman)'s Short Interest. How do I buy shares of WuXi Biologics (Cayman)? Shares of WXXWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WXXWY) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi Biologics (Cayman) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.